Release date: July 13, 2023
Expiration date: July 12, 2025
Estimated Time of Completion: 1 hour
Session Agenda:
Pain recovery: Cleveland Clinic experience
Pavan Tankha, DO, Cleveland, Clinic
Exploring the Social and Scientific Fundamentals of Chronic Pain
Annual R.J. Fasenmeyer Annual Lectureship
Haider Warraich, MD, VA Boston Healthcare System, Brigham and Women's Hospital
Description
Watch Biologic Therapies Summit X and Vasculitis Online Series, on-demand, complimentary webcasts that brings together world leaders in immune-based therapies to address cutting-edge topics in immunology and rheumatology. Education focuses on vasculitis, including key issues in the differential diagnosis of vasculitis, CNS vasculitis, ANCA-associated vasculitis, and organ-specific issues in vasculitis. In addition, the online series features talks on CAR T-cell therapy, irAEs, precision medicine and the next generation of JAK inhibitors for IMIDs, and advances in complement biology and therapy. A deep dive into rheumatoid arthritis, AS, PsA and SpA, infections, COVID-19, co-morbidities with IMIDs, including ILD and cardiovascular risk in immune-mediated diseases, and lupus. Lastly, the CE-certified webcasts address pain management and the exploration of the social and scientific fundamentals of pain.
Learning Objectives
- Highlight the insights and advancements in Pain and Pain Management.
- Define pain pathways, how we understand them, and how they impact the ways we manage pain in patients.
- Review the significance of Comprehensive Pain Recovery and the Biopsychosocial Model.
- Interpret the fluidity and manefestations of pain throughout the body and its systems.
- Discuss the impact Neuropathic Pain has on the Memory of Pain and how it is experienced physically.
- Rreview the history of Pain Management and the evolution of treatments and approach to treatment as a whole.
- Highlihght the myths and perceptions of pain among difference races and ethnicities.
Target Audience
The online series is directed to rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians, pharmacists, nurse practitioners, nurses, and physician assistants interested in or using biologic therapeutics for autoimmune and autoinflammatory disorders.
Accreditation
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians / American Medical Association (AMA)
Cleveland Clinic Foundation Center for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Nurses / American Nurses Credentialing Center (ANCC)
Cleveland Clinic Center for Continuing Education designates this enduring activity for a maximum of 1.0 ANCC contact hours.
Physician Assistants / American Academy of PAs (AAPA)
Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Interprofessional Continuing Education (IPCE) Credit
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.
Activity Director and Faculty
Activity Director
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH
M. Elaine Husni, MD, MPH
Director, Arthritis and Musculoskeletal Treatment Center
Vice Chair of Rheumatology
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH
Carol Langford, MD, MHS
Director, Center for Vasculitis Care and Research
Department of Rheumatologic and Immunologic Disease
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH
Planning Committee
Cassandra Calabrese, DO
Department of Rheumatologic and Immunologic Disease
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH
Elizabeth (Betsy) Kirchner, DNP
Department of Rheumatologic and Immunologic Disease
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH
Amanda Mixon, PA-C
UCHealth Rheumatology Clinic - Harmony Campus
University of Colorado Health
Fort Collins, CO
Faculty
Pavan Tankha, DO
Medical Director, Center for Comprehensive Pain Recovery
Neurological Institute
Cleveland Clinic
Cleveland, OH
Haider Warraich, MD
Associate Director, Heart Failure Program
VA Boston Healthcare System
Associate Physician, Brigham and Women's Hospital
Boston, MA
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Disclosures
| Cassandra Calabrese, DO |
Astra Zeneca, Lilly |
Consulting |
Sanofi-Regeneron |
Consulting
Teaching and Speaking |
| Leonard Calabrese, DO |
Astra Zeneca, BMS |
Teaching and Speaking |
Novartis, Regeneron, Sanofi Aventis |
Consulting |
Genentech/Roche |
Consulting
Advisor or review panel participant
Teaching and Speaking |
Abbvie Pharmaceuticals, Janssen, UCB |
Consulting
Teaching and Speaking |
| M. Elaine Husni, MD, MPH |
Abbvie Pharmaceuticals, Amgen, Bristol-Myers Squibb Co, Genzyme/Sanofi, Janssen, Lilly, Regeneron |
Consulting
Advisor or review panel participant |
Celgene Corporation, Pfizer, Inc. |
Advisor or review panel participant |
Genenetch, UCB, Inc. |
Consulting |
Novartis Pharmaceuticals |
Consulting
Advisor or review panel participant
Teaching and Speaking |
WebMD |
Consulting
Teaching and Speaking |
| Elizabeth Kirchner, DNP |
Janssen Pharmaceuticals, Inc. |
Consulting |
RhAPP |
Teaching and Speaking |
Boehringer Ingelheim, Horizon Pharma, UCB |
Advisor or review panel participant |
| Carol Langford, MD |
Astrazeneca Pharmaceuticals |
Other activities from which remuneration is received or expected: Non-paid consultant for research Clinical trial funding support - this has ended |
Bristol-Myers Squibb Co. |
Other activities from which remuneration is received or expected: Clinical trial funding support Non- paid consultant for research |
Chemocentryx, GlaxoSmithKline |
Other activities from which remuneration is received or expected: Clinical trial funding support |
Abbvie Pharmaceuticals |
Other activities from which remuneration is received or expected: Non- paid consultant for research |
| Amanda Mixon, PA-C |
Abbvie Pharmaceuticals |
Consulting
Advisor or review panel participant
Teaching and Speaking |
Eli Lilly, Janssen Pharmaceuticals, Inc |
Advisor or review panel participant
Teaching and Speaking |
Amgen |
Teaching and Speaking |
Astrazeneca Pharmaceuticals, RhAPP, Sanofi |
Advisor or review panel participant |
UCB, Inc. |
Consulting |
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Pavan Tankha, DO
Haider Warraich, MD
Acknowledgment
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this live activity from:
AbbVie, Inc.
Amgen, Inc.
AstraZeneca Pharmaceuticals
Bristol Myers Squibb
Genentech
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
Pfizer, Inc.
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this enduring activity from:
AbbVie, Inc.
Amgen, Inc.
AstraZeneca Pharmaceuticals
Bristol Myers Squibb
Genentech
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education, Cleveland Clinic’s R.J Fasenmyer Center for Clinical Immunology.
